- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
-
domain (RBD) of SARS-CoV-2 Y COVID-19
Relatlimab mab
human LAG3
melanoma Remtolumab mab
human IL-17A, TNF
Reslizumab Cinqair mab
humanized IL-5 Y inflammations...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
- E (interleukin 25), F) Antibodies:
Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists:
Iboctadekin Interleukin 18 Interleukin...
